Clinical studies recruiting near Santa Rosa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Sutter Santa Rosa · Bristol-Myers Squibb · NCT07106762 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT05564390 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Providence Medical Foundation - Santa Rosa · Alliance for Clinical Trials in Oncology · NCT07091617 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Kaiser Permanente-Santa Rosa · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Santa Rosa · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Kaiser Permanente-Santa Rosa · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente-Santa Rosa · Alliance for Clinical Trials in Oncology · NCT06931340 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente-Santa Rosa · Alliance for Clinical Trials in Oncology · NCT06876714 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Providence Medical Foundation - Santa Rosa · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Providence Medical Foundation - Santa Rosa · SWOG Cancer Research Network · NCT05806515 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Santa Rosa · NRG Oncology · NCT06748222 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT06498635 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Santa Rosa · NRG Oncology · NCT04852887 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Boehringer Ingelheim · NCT06632457 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Kaiser Permanente-Santa Rosa · Alliance for Clinical Trials in Oncology · NCT05677490 Galleri® in the Medicare Population.
NA · Sutter Health Santa Rosa · GRAIL, Inc. · NCT05673018 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Providence Medical Foundation - Santa Rosa · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Providence Medical Foundation - Santa Rosa · SWOG Cancer Research Network · NCT04511013 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Kaiser Permanente-Santa Rosa · Wake Forest University Health Sciences · NCT04462302 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Providence Medical Foundation - Santa Rosa · SWOG Cancer Research Network · NCT04205968 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Providence Medical Group - Santa Rosa · Mirati Therapeutics Inc. · NCT04613596 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT06317649 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT05675410 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Kaiser Permanente-Santa Rosa · SWOG Cancer Research Network · NCT03418961 Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · Providence Medical Foundation - Santa Rosa · ECOG-ACRIN Cancer Research Group · NCT06002828 Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT06029270 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Providence Medical Foundation - Santa Rosa · SWOG Cancer Research Network · NCT03723928 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · Providence Medical Foundation - Santa Rosa · ECOG-ACRIN Cancer Research Group · NCT06475989 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Kaiser Permanente-Santa Rosa · National Cancer Institute (NCI) · NCT06422806

Look up another city

Look up another condition